AndreaBozzo/ceres-open-data-index huggingface dataset:
Quality Assurance Reporting Requirements (QARR) Health Disparities 2021

This dataset includes Medicaid Managed Care, Commercial HMO, and Commercial PPO performance data from the Quality Assurance Reporting Requirements (QARR) by member demographic characteristics. QARR is largely based on measures of quality developed and published by the National Committee for Quality Assurance (NCQA) Healthcare Effectiveness Data and Information Set (HEDIS®). Plans are required to submit quality performance data each year. Demographic information analyzed in this report includes members’ sex, age, race/ethnicity, Medicaid aid category, cash assistance status, behavioral health conditions including serious mental illness (SMI) and substance use disorder (SUD), payer status, and region of residence. Measuring the quality of care, and the ability to measure disparities in care is an important first step to a better understanding of the underlying factors that drive differences in care among certain populations within Medicaid Managed Care, Commercial HMO, and Commercial PPO.

These data are published annually for Medicaid Managed Care in the Health Care Disparities in New York State Report and on the NYSDOH web site: http://www.health.ny.gov/health_care/managed_care/reports/quality_performance_improvement.htm#link6
FY 2009 Children's Bureau Discretionary Grant Awards

This document provides a list of Children's Bureau discretionary grants awarded in fiscal year 2009:

National Resource Center for Child Welfare Organizational Improvement (CFDA # 93.556)
Up to $1,400,000 per year for up to 5 years.

National Resource Center for Child Protective Services (CFDA # 93.670)
Up to $1,200,000 per year for up to 5 years.

National Child Welfare Resource Center on Legal and Judicial Issues (CFDA # 93.670)
Up to $1,150,000 per year for up to 5 years.

National Resource Center for In-Home Services (CFDA # 93.670)
Up to $950,000 per year for up to 5 years.

National Resource Center for Permanency and Family Connections (CFDA # 93.556)
Up to $1,150,000 per year for up to 5 years.

National Resource Center for Adoption (CFDA # 93.652)
Up to $1,200,000 per year for up to 5 years.

National Resource Center for Youth Development (CFDA # 93.556)
Up to $1,250,000 per year for up to 5 years.

National Resource Center for Child Welfare Data and Technology (CFDA # 93.658)
Up to $1,500,000 per year for up to 5 years.

National Resource Center for Tribes (CFDA # 93.658)
Up to $875,000 per year for up to 5 years.

National Resource Center for Community-Based Child Abuse Prevention (CFDA # 93.590)
Up to $1,400,000 per year for up to 5 years.

Rigorous Evaluations of Existing Child Abuse Prevention Programs (CFDA # 93.670)
Up to $200,000 per year for up to 5 years.

Abandoned Infants Assistance Act: Comprehensive Support Services for Families affected by Substance Abuse and/or HIV/AIDS (CFDA # 93.551)
Up to $475,000 per year for up to 4 years.

National Quality Improvement Center on the Representation of Children in the Child Welfare System (CFDA # 93.652)
Up to $1,000,000 per year for up to 5 years.

Family Connection Discretionary Grants (CFDA # 93.605)
Up to $1,000,000 per year for up to 3 years.

Tribal Title IV-E Plan Development Grants (CFDA # 93.658)
Up to $300,000 per 2-year budget/project period.

Metadata-only record linking to the original dataset. Open original dataset below.
Compound 526830: 14-Hydroxy-arachidic, methyl ester, tBDMS ether

Chemical compound data from PubChem database. IUPAC Name: methyl 14-[tert-butyl(dimethyl)silyl]oxyicosanoate. Molecular Formula: C27H56O3Si. Molecular Weight: 456.8. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 527785: Benzoic acid, 2-chloro, 3-butenyl ester

Chemical compound data from PubChem database. IUPAC Name: but-3-enyl 2-chlorobenzoate. Molecular Formula: C11H11ClO2. Molecular Weight: 210.65. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Women, Infants, and Children (WIC) Program Eligibility Criteria

This dataset includes eligibility criteria for participation in the Special Supplemental Nutrition Program for Women, Infants and Children (WIC).  WIC offers nutrition education, breastfeeding support, referrals, and a variety of nutritious foods to low-income pregnant, breastfeeding, or postpartum women, infants, and children up to age five to promote and support good health. To be eligible to receive WIC benefits, specific eligibility requirements must be met, including categorical, residential, income, and nutritional risk criteria.
Patent AT-E401555-T1: [Translated] CORIOLIS FLOW METER AND METHOD FOR DETERMINING A SIGNAL DIFFERENCE IN WIRING AND FIRST AND SECOND PICKOFF SENSORS

Chemical patent from PubChem database. Patent Number: AT-E401555-T1. Title: Combinatorial Chemistry Method. Filing Date: 2009-05-11. Inventors: Smith, John A., Johnson, Mary B.. Abstract: A combinatorial chemistry method for generating libraries of chemical compounds is disclosed, enabling rapid identification of lead compounds for drug... IPC Classifications: C07H, A61K, A61P. This patent covers 12 claims related to 9 chemical compounds. Useful for intellectual property research, prior art searches, and chemical innovation tracking.
South (S)

This report presents the South\'s (e.g., combines Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, and West Virginia) estimates for 25 measures of substance use and mental health based on the combined 2009 and 2010 National Surveys on Drug Use and Health (NSDUHs). Topics covered include past month substance use (e.g., illicit drugs, marijuana, cocaine, pain relievers, alcohol, tobacco), substance dependence, abuse, and treatment need, past year serious mental illness (SMI), any mental illness (AMI), suicidal thoughts, and major depressive episode (MDE). Resuts are provided for the South for five age groups: 12 to 17, 18 to 25, 26 or older, 18 or older and all persons 12 or older.
Patent AT-E400329-T1: [Translated] GLOVE REINFORCEMENT ELEMENT

The invention concerns a glove reinforcing element (1), in particular for a goal-keeper glove, which allows a bending in gripping direction but which avoids a hyperextension of the fingers and/or the hand. The glove reinforcing element comprises at least one bending area (10), wherein the bending area (10) has a curvature with a shape which allows to bend the glove reinforcing element (1) into at least a first direction and which blocks a bending of the glove reinforcing element (1) into at least a second direction.
2012 Uniform Reporting System (URS) Tables for New Mexico

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for 2012. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Development of a thermal spray coating aerosol generator and inhalation exposure system

Thermal spray coating involves spraying a product that is melted by extremely high temperatures and then applied under pressure under pressure onto a surface. Large amounts of a complex metal aerosol (e.g., Fe, Cr, Ni, Zn) are formed during the process, presenting a potentially serious risk to the operator. Information about the health effects associated with exposure to these aerosols is lacking. Even less is known about the chemical and physical properties of these aerosols. The goal was to develop and test an automated thermal spray coating aerosol generator and inhalation exposure system that would simulate workplace exposures. An electric arc wire- thermal spray coating aerosol generator and exposure system was designed and separated into two areas: (A) an enclosed room where the spray coating occurs; (B) an exposure chamber with different measurement devices and controllers. The physicochemical properties of aerosols generated during electric arc wire- thermal spray coating using five different consumable wires were examined. The generated particles regardless of composition were poorly soluble, complex metal oxides and mostly arranged as chain-like agglomerates and similar in size distribution as determined by MOUDI and ELPI. To allow for continuous, sequential spray coating during a 4-hr exposure period, a motor rotated the metal pipe to be coated in a circular and up-and-down direction. In a pilot animal study, male Sprague-Dawley rats were exposed to aerosols (25 mg/m3 x 4 hr/d x 9 d) generated from electric arc wire- thermal spray coating using a stainless-steel PMET720 consumable wire. The targeted exposure chamber concentration was achieved and maintained during a 4-hr period. At 1 d after exposure, lung injury and inflammation were significantly elevated in the group exposed to the thermal spray coating aerosol compared to the air control group. A thermal spray coating inhalation system was designed and constructed that will generate continuous metal spray coating aerosols at a targeted concentration for extended periods of time without interruption for future animal exposure studies.
NNDSS - Table II. Invasive Pneumococcal to Legionellosis

NNDSS - Table II. Invasive Pneumococcal to Legionellosis - 2015.In this Table, provisional cases of selected notifiable diseases (≥1,000 cases reported during the preceding year), and selected low frequency diseases are displayed. The Table includes total number of cases reported in the United States, by region and by states, in accordance with the current method of displaying MMWR data.  Data on United States exclude counts from US territories. Note:These are provisional cases of selected national notifiable diseases, from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data reported by the 50 states, New York City, the District of Columbia, and the U.S. territories are collated and published weekly as numbered tables printed in the back of the Morbidity and Mortality Weekly Report (MMWR). Cases reported by state health departments to CDC for weekly publication are provisional because of ongoing revision of information and delayed reporting. Case counts in this table are presented as they were published in the MMWR issues. Therefore, numbers listed in later MMWR weeks may reflect changes made to these counts as additional information becomes available. Footnotes:C.N.M.I.: Commonwealth of Northern Mariana Islands. U: Unavailable.    -: No reported cases.    N: Not reportable.    NN: Not Nationally Notifiable.    NP: Nationally notifiable but not published.    Cum: Cumulative year-to-date counts.    Med: Median.    Max: Maximum. * Three low incidence conditions, rubella, rubella congenital, and tetanus, have been moved to Table 2 to facilitate case count verification with reporting jurisdictions. ��� Case counts for reporting year 2015 are provisional and subject to change. For further information on interpretation of these data, see http://wwwn.cdc.gov/nndss/document/ProvisionalNationaNotifiableDiseasesSurveillanceData20100927.pdf. Data for TB are displayed in Table IV, which appears quarterly. �� Includes drug resistant and susceptible cases of Invasive Pneumococcal Disease. This condition was previously named Streptococcus pneumoniae invasive disease and cases were reported to CDC using different event codes to specify whether the cases were drug resistant or in a defined age group, such as <5 years. Since 2010, case notifications for this condition were consolidated under one event code for Invasive pneumococcal disease.
Arkansas (AR)

This report presents estimates for measures of substance use and mental health based on the combined 2010 and 2011 National Surveys on Drug Use and Health (NSDUHs). Topics covered include past month substance use (e.g., illicit drugs, marijuana, cocaine, pain relievers, alcohol, tobacco), substance dependence, abuse, and treatment need, past year serious mental illness (SMI), any mental illness (AMI), suicidal thoughts, and major depressive episode (MDE). Resuts are provided for Arkansas for five age groups: 12 to 17, 18 to 25, 26 or older, 18 or older and all persons 12 or older.
Patent AT-E401101-T1: [Translated] EXPRESS SET AND FUNNEL INSERT FOR BREAST PUMPING DEVICES

The present invention relates to a breast pump comprising a pump that produces both vacuum and pulsating pressure, at least one express kit, and hoses or the like for connecting the pump to the express kit. The express kit comprises a manifold, a milk collection vessel, a rigid cup and a flexible liner (80). The liner (80) is made of a pliable material, and includes a funnel and a throat (84). The inside surface of the funnel, which is between the liner (80) and the cup when the liner (80) is installed, has an optional honeycomb structure that creates a forced space between the liner (80) and the cup, while maintaining some degree of flexibility. At the end of the liner (80) inside the throat (84), a rigid insert (92) or suitable bond maintains some rigidity inside the throat (84), supports the liner (80) and creates a seal between the liner (80) and the cup at the throat end of the liner. <IMAGE>
Connecticut (CT)

This report presents estimates for measures of substance use and mental health based on the combined 2010 and 2011 National Surveys on Drug Use and Health (NSDUHs). Topics covered include past month substance use (e.g., illicit drugs, marijuana, cocaine, pain relievers, alcohol, tobacco), substance dependence, abuse, and treatment need, past year serious mental illness (SMI), any mental illness (AMI), suicidal thoughts, and major depressive episode (MDE). Resuts are provided for Connecticut for five age groups: 12 to 17, 18 to 25, 26 or older, 18 or older and all persons 12 or older.
Compound 528796: Cyclotricosasiloxane, hexatetracontamethyl

Chemical compound data from PubChem database. IUPAC Name: 2,2,4,4,6,6,8,8,10,10,12,12,14,14,16,16,18,18,20,20,22,22,24,24,26,26,28,28,30,30,32,32,34,34,36,36,38,38,40,40,42,42,44,44,46,46-hexatetracontamethyl-1,3,5,7,9,11,13,15,17,19,21,23,25,27,29,31,33,35,37,39,41,43,45-tricosaoxa-2,4,6,8,10,12,14,16,18,20,22,24,26,28,30,32,34,36,38,40,42,44,46-tricosasilacyclohexatetracontane. Molecular Formula: C46H138O23Si23. Molecular Weight: 1705.5. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Pennsylvania (PA)

This report presents Pennsylvania\'s estimates for 25 measures of substance use and mental health based on the combined 2009 and 2010 National Surveys on Drug Use and Health (NSDUHs). Topics covered include past month substance use (e.g., illicit drugs, marijuana, cocaine, pain relievers, alcohol, tobacco), substance dependence, abuse, and treatment need, past year serious mental illness (SMI), any mental illness (AMI), suicidal thoughts, and major depressive episode (MDE). Resuts are provided for Pennsylvania for five age groups: 12 to 17, 18 to 25, 26 or older, 18 or older and all persons 12 or older.
Patent AT-E401067-T1: [Translated] USE OF 4-HYDROXYTAMOXIFEN IN THE PRODUCTION OF A MEDICATION FOR THE TREATMENT OF GYNECOMASTIA

The present invention provides methods for treating and preventing gynecomastia by administering 4-hydroxy tamoxifen to a patient. When percutaneously administered to a patient's breasts, 4-hydroxy tamoxifen concentrates locally, and exerts an anti-estrogenic effect. In patients with gynecomastia, this reduces the effective estrogen-androgen ratio in the breast tissue, thereby reducing ductal proliferation, epithelial and stromal hyperplasia, and pain. In patients at risk for developing gynecomastia, 4-hydroxy tamoxifen's anti-estrogenic effect prevents tissue proliferation and its accompanying pain.
Compound 527237: (3S,3aS,6R,7S,8aS)-3,7,8,8-Tetramethyloctahydro-1H-3a,6-methanoazulen-7-ol

Chemical compound data from PubChem database. IUPAC Name: 2,6,6,7-tetramethyltricyclo[6.2.1.01,5]undecan-7-ol. Molecular Formula: C15H26O. Molecular Weight: 222.37. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Chemical Carcinogenesis Research Information System (CCRIS)

The Chemical Carcinogenesis Research Information System (CCRIS) database contains chemical records with carcinogenicity, mutagenicity, tumor promotion, and tumor inhibition test results. It was developed by the National Cancer Institute (NCI). Data are derived from studies cited in primary journals, current awareness tools, NCI reports, and other sources. Test results have been reviewed by experts in carcinogenesis and mutagenesis. CCRIS provides historical information from the years 1985 - 2011. It is no longer updated.
CMS Medicare PSI-90 and component measures - six-digit estimate dataset

This data set includes the Patient Safety and Adverse Events Composite measure (CMS Medicare PSI 90) and the individual CMS Patient Safety Indicators. CMS Medicare PSI 90 is a composite complication measure composed from 10 separate Patient Safety Indicators. The measure provides an overview of hospital-level quality as it relates to a set of potentially preventable hospital-related events associated with harmful outcomes for patients.
Compound 528828: alpha, beta, beta 20R 24S-METHYLCHOLESTANE

Chemical compound data from PubChem database. IUPAC Name: 17-(5,6-dimethylheptan-2-yl)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene. Molecular Formula: C28H50. Molecular Weight: 386.7. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 527724: Propanoic acid, 2,3-dibromo, 4-methylpentyl ester

Chemical compound data from PubChem database. IUPAC Name: 4-methylpentyl 2,3-dibromopropanoate. Molecular Formula: C9H16Br2O2. Molecular Weight: 316.03. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Nursing Home Chain Performance Measures

The Nursing Home Chain Performance Measures dataset provides select quality and performance measures from Care Compare for groups of nursing homes that share common individual or organizational owners, officers, or entities with operational/managerial control. The data include measures such as average health and staffing star ratings, staffing measures, average quality star ratings, select enforcement remedies, claims-based and Minimum Data Set (MDS) measures, and average Skilled Nursing Facility Quality Reporting Program (SNF QRP) metrics.
Compound 529391: bis-(2-Methyl-3-furyl) disulfide

Chemical compound data from PubChem database. IUPAC Name: 3-(furan-3-yldisulfanyl)-2-methylfuran. Molecular Formula: C9H8O2S2. Molecular Weight: 212.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
High-throughput genotyping of single nucleotide polymorphisms with rolling circle amplification

Background
          Single nucleotide polymorphisms (SNPs) are the foundation of powerful complex trait and pharmacogenomic analyses. The availability of large SNP databases, however, has emphasized a need for inexpensive SNP genotyping methods of commensurate simplicity, robustness, and scalability.
          We describe a solution-based, microtiter plate method for SNP genotyping of human genomic DNA. The method is based upon allele discrimination by ligation of open circle probes followed by rolling circle amplification of the signal using fluorescent primers. Only the probe with a 3' base complementary to the SNP is circularized by ligation.
        
        
          Results
          SNP scoring by ligation was optimized to a 100,000 fold discrimination against probe mismatched to the SNP. The assay was used to genotype 10 SNPs from a set of 192 genomic DNA samples in a high-throughput format. Assay directly from genomic DNA eliminates the need to preamplify the target as done for many other genotyping methods. The sensitivity of the assay was demonstrated by genotyping from 1 ng of genomic DNA. We demonstrate that the assay can detect a single molecule of the circularized probe.
        
        
          Conclusions
          Compatibility with homogeneous formats and the ability to assay small amounts of genomic DNA meets the exacting requirements of automated, high-throughput SNP scoring.
Deficit Reduction Act Hospital-Acquired Condition Measures

The Publicly Reported Deficit Reduction Act (DRA) Hospital-Acquired Condition (HAC) Measures data provides information on hospital-level measures rates for four of the HACs included in the DRA HAC payment provision – foreign object retained after surgery, blood incompatibility, air embolism, and falls and trauma – for Medicare fee-for-service discharges. The Publicly Reported DRA HAC Measures are reported only for informational and quality improvement purposes; the results of the measure calculations do not affect payment and are not a part of the HAC Reduction Program.
Trend Tables  (Prevalence Estimates) - 7.1 to 7.45

These detailed tables show trends in population totals and prevalence estimates of illicit drug use, risk and protective factors, substance initiation, substance dependence/abuse, and need/receipt of substance use treatment from the 2011 National Survey on Drug Use and Health (NSDUH). Substances examined include illicit drugs (e.g., marijuana, cocaine, heroin, hallucinogens (including LSD, PCP, Ecstasy, Ketamine, DMT/AMT/Foxy, Salvia divinorum), inhalants, and the nonmedical use of prescription-type pain relievers (including OxyContin), tranquilizers, stimulants (Adderall) , sedatives (GHB, Ambien), non-prescription cold medicine, alcohol, and tobacco products (including cigarettes, smokeless tobacco, cigars, pipes). Results are provided for lifetime, past year, and past month use by age group, gender, race/ethnicity, education level, employment status, and geographic area. Comparisons are made between 2011 and 2002 through 2010.
Compound 530198: Indole-3-glycolic acid, TMS

Chemical compound data from PubChem database. IUPAC Name: trimethylsilyl 2-(1-trimethylsilylindol-3-yl)oxyacetate. Molecular Formula: C16H25NO3Si2. Molecular Weight: 335.54. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
2014 CMHS Uniform Reporting System (URS) Table for New Hampshire

2014 Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for New Hampshire. The URS state reporting system is collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.